{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T04:48:31Z","timestamp":1681274911487},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ijcard.2005.03.025","type":"journal-article","created":{"date-parts":[[2005,5,8]],"date-time":"2005-05-08T00:47:47Z","timestamp":1115513267000},"page":"241-246","source":"Crossref","is-referenced-by-count":4,"title":["Downstream administration of a high-dose tirofiban bolus in high-risk patients with unstable angina undergoing early percutaneous coronary intervention"],"prefix":"10.1016","volume":"107","author":[{"given":"Gian B.","family":"Danzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Sesana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Predolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Baglini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2005.03.025_bib1","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0140-6736(01)06585-0","article-title":"Acute coronary syndrome without ST elevation: implementation of new guidelines","volume":"358","author":"Hamm","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2005.03.025_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/pcad.2001.29143","article-title":"Intravenous glycoprotein IIb\/IIIa inhibition in non-ST segment elevation acute coronary syndromes","volume":"44","author":"Chew","year":"2001","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2005.03.025_bib4","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","article-title":"Inhibition of the platelet glycoprotein IIb\/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction","volume":"338","author":"The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators","year":"1998","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.ijcard.2005.03.025_bib5","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndrome treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.025_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/01.CIR.96.5.1445","article-title":"Effects of platelet glycoprotein IIb\/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty","volume":"96","author":"The RESTORE Investigators","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.025_bib7","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","author":"Topol","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.025_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9149(01)02319-0","article-title":"Suboptimal early inhibition of platelets by treatment with tirofiban and implication for coronary interventions","volume":"89","author":"Kabbani","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0002-9149(02)02329-9","article-title":"Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention","volume":"89","author":"Herrmann","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib10","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0002-9149(02)02892-8","article-title":"Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban","volume":"90","author":"Schneider","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0002-9149(02)03163-6","article-title":"Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus dose of tirofiban","volume":"91","author":"Schneider","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial: phase 1 findings","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2005.03.025_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/(SICI)1522-726X(199912)48:4<435::AID-CCD21>3.0.CO;2-8","article-title":"A deterministic approach to automated stenosis quantification","volume":"48","author":"Tommasini","year":"1999","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2005.03.025_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.CIR.78.2.486","article-title":"Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology\/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures","volume":"78","author":"Ryan","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2005.03.025_bib15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (cooling-off strategy) before intervention in patients with unstable coronary syndromes. A randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2005.03.025_bib16","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1067\/mhj.2000.103741","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockers: an appropriate-use model for expediting care in acute coronary syndromes","volume":"139","author":"Kereiakes","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2005.03.025_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/ccd.10734","article-title":"Safety of high bolus dose of tirofiban during stent placement","volume":"61","author":"Danzi","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2005.03.025_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.amjcard.2004.03.026","article-title":"Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function","volume":"94","author":"Danzi","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2004.03.042","article-title":"The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty. The ADVANCE trial","volume":"44","author":"Valgimigli","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2005.03.025_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low dose heparin during percutaneous coronary revascularisation","volume":"336","author":"The EPILOG Investigators","year":"1997","journal-title":"N Engl J Med"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305005693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527305005693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T16:57:50Z","timestamp":1548521870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527305005693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0167527305005693"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2005.03.025","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}